loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 209509 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 AMBRISENTAN (2)

filter

01 PAR PHARM INC (2)

filter

01 TABLET;ORAL (2)

filter

01 10MG (1)

02 5MG (1)

filter

01 USA (2)

URL Supplier Web Content
TABLET;ORAL
5MG
AMBRISENTAN
USA
209509
2019-04-10
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET;ORAL
10MG
AMBRISENTAN
USA
209509
2019-04-10
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 209509

Looking for CTD TGA MCC DOSSIER APPLICATION 209509 2

19

Par Pharmaceutical, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is AMBRISENTAN, with a corresponding application number 209509 and regulatory information .

proudly manufactured in the

approval since 2019-04-10

Par Pharmaceutical's AMBRISENTAN TABLET;ORAL, medication with 5MG of AMBRISENTAN.

18

Par Pharmaceutical, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is AMBRISENTAN, with a corresponding application number 209509 and regulatory information .

proudly manufactured in the

approval since 2019-04-10

Par Pharmaceutical's AMBRISENTAN TABLET;ORAL, medication with 10MG of AMBRISENTAN.

Post Enquiry
POST ENQUIRY